RA is currently treated with nonsteroidal anti-inflammatory drugs (NSAIDs), as these drugs prevent prostaglandin synthesis by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2) and thereby act against inflammation and pain. The gene discussed is PTGS2; the disease is rheumatoid arthritis.